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The nature ofT cells contained within cutaneous lesions of 
cutaneous T-celllymphoma (CTCL) has not been studied at 
the clonal level. T cells extracted from skin lesions of two 
CTCL patients were cloned by limiting dilution and propa-
gated in interleukin-2 (IL-2) containing medium with peri-
odic lectin stimulation. Twelve T-cell clones were derived 
from each patient. In both cases, genotypic analysis of the 
T -cell clones revealed that these clones had T -cell receptor 
(TCR) P- and )'-chain gene rearrangements distinct from the 
predominant, presumably malignant, clone present in the 
skin, lymph nodes, or blood. This suggests that they were 
derived from presumably reactive (non-malignant) T cells. 
C uraneous T-celllymphoma (CTCL) is a malignancy of T cells that primarily affects the skin. Mycosis fungoides, rhe most common type of CTCL, is often characterized by a long latent period and an indolent clintcal course [1]. Unlike most lymphomas, CTCL 
les10ns, even at a late stage. often contain a polymorphous infiltrate 
comprised not only of malignant T cells but also normal-appearing 
lymphocytes, macrophages, and other inflammatory cells. These 
unusual features of CTCL prompted us to begin ro address three 
questions: i) whether non-malignant, reactive T cells [so-called 
rumor mfiltratmg lymphocytes (TIL)] are present in lesions of 
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Furthermore, these clones had gene rearrangements different 
from each other, indicating their multiple clonal origins. The 
failure to propagate in vitro the CTCL T -cell clone suggests 
that CTCL cells may have growth requirements different 
from normal T cells. Thus, conventional T-cell culturing 
methods using IL-2 and lectins as mitogen may selectively 
propagate the presumably reactive T cells contained within 
the skin lesions. The ability to selectively grow these reactive 
lesional T cells (so-called tumor infiltrating lymphocytes) 
raises the possibility that these cells could be used in adoptive 
immunotherapy of CTCL. J Invest Derma col 9 5:4-8, 1990 
CTCL; ii) whether these TIL can modulate the growth of the 
rumor cells; and iii) whether they can ultimately be harnessed to 
treat CTCL patients. 
Adoptive immunotherapy using TIL has recently been demon-
strated to be effective in the treatment of advanced solid tumors [2]. 
In this form of therapy, autologous TIL are extracted from rumors, 
expanded in vitro by stimulation with interleukin-2 (IL-2) and phy-
rohemaglutinin (PHA), and infused into the patient. TIL adoptive 
immunotherapy is more potent and less roxie than immunotherapy 
using lymphokine activated killer (LAK) cells. So far, TIL adoptive 
immunotherapy has not been applied to the treatment of CTCL. 
Whether such therapy could be useful in CTCL would depend 
upon developing a method for the selective Isolation of TIL. 
In this study, we attempted to propagate in vttro CTCL cells and 
TIL isolated from CTCL skin lesions. In order to avoid in vitro 
cytolysis of the malignant T cells by the TIL, rhe T cells were 
cloned as soon as possible following extraction from the tissue. As 
there are no reliable surface markers that specifically distinguish 
malignant cells from normal T cells, we made use of the unique 
nature of the T-cell receptor (TCR) gene rearrangement of each 
clonal T -cell population to distinguish malignant and non-malig-
nant T cells. It is assumed that rhe TCR gene rearrangement dem-
onstrated in a CTCL skin tumor represents the rearrangement of 
the malignant (predominant) clone within the lesion; a cultured 
T -cell clone with a TCR gene rearrangement 1denttcal to that of the 
skin les10n from which it was derived would represent the malig-
nant clone; clones with non-matching genotypic configuranon 
would presumably represent non-malignant, reactive TIL. 
Our data mdicate that CTCL skm lesions contam T cells of mul-
tiple clonal lineages which are distinct from the predominant (pre-
sumably malignant) clone present in the skin les1on. These presum-
ably non-malignant, reactive cells could be expanded in vitro, 
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virtually free of the malignant cells. Whether these cells modulate 
the growth of the malignant clone and whether they have any 
therapeutic utthty remams to be determined. 
MATERIALS AND METHODS 
P atients The clinical data on the rwo patients studied in chis 
report arc summarized in Table I. In both cases, the diagnosis of 
CTCL was based on the characteristic clinical presentation as well as 
histologic evidence of the presence of an atypical T-cell infiltrate, 
epidermotop1sm, and Pautrier micro-abscesses (Fig 1). In patient 2, 
large numbers of Sezary cel ls (4.5 X 1010/L) were also present in the 
peripheral blood. . 
After the diagnosis of CTCL was confirmed, rwo 6-mm skm 
punch b1opsy specimens were .obtained from a.single represent.ative 
CTCL plaque (designated les1on A) from panenc 1; one spectmen 
was used for T CR gene rearrangement determinacion and the o~her 
was used forT-cell culturing and cloning. Subsequencly, the panent 
progressed from plaque stage to tumor stage CTCL, and a biopsy of 
a tumor (designated lesion B) was obtained for T CR gene rearrange-
ment analysis. 
Ten millihters of peripheral blood and a 6-mm skin punch biopsy 
from a lesion on the buttock were obtained from patient 2 for T CR 
gene rearrangement studies. Another biopsy from the same lesion 
was taken forT-cell cloning and culturing. 
T -Cell C ulturing and C loning from Lesional Skin T cells 
were extracted from a 6-mm skin biopsy specimen by incubating the 
minced tissue fragments in RPMI 1640 medium (Gibco) containing 
10% AB serum (Sigma), 50 unics/ ml recombinant interleukin-2 
(r!L-2) (Roche, Nutley, NJ), and 1 o/o penicillin/streptomycin in a 
24-well nssue culture place. The tissue fragments were removed 
after 24 h. After 4 d of in vitro culrure, the T cells chat had nugrated 
out of the tissue were cloned by limiting dilution atO.S cell per well. 
Cultures were maintained in IL-2 with thrice weekly media 
changes and stimulated bi-weekly with PHA and gamma-irradiated 
autologous mononuclear cells. The monon'!clear cells were isol~ccd 
from the patients' peripheral blood by F1coll Hypaq~e gr~d~ent 
separanon and then subjected to 5000 rad of gamma mad1at1on. 
Th1s dose of radiation was previously determined to be sufficient co 
arrest mitogen-induced shore-term cell pro liferation and co prevent 
long-term cell growth under the above conditions. Cultures were 
monitored daily by phase microscopy. After a clone had expanded 
sufficiently, 5 X 106 cells were harvested for TCR gene rearrange-
ment studies. 
DNA Blot H ybridization Analysis High molecular weight 
DNA was extracted from 6-mm skin bioJ>SJ specimens by modifica-
tions of the method ofBiin and Stafford l3J. Briefly, fresh tissue was 
rapidly frozen in liquid nitrogen, wrapped in foil, ~nd pulverized 
with a hammer. Liquid nitrogen was added to che tiSsue, as neces-
Table I. Patient Characteristics 
------
Patient I Panent 2 
Age 65 70 
Sex M M 
Presentation Scaly plaques, nodules Erythroderma, 
H1~tology Atypical lymphocytic 
anlilrrate, epidermo-
indurated plaques 
Similar 
lmmunophenorype 
trOpiSm 
CD4+, CD3+, C02"", CD4 ', CDJ+, C02•, 
cos- cos-
D1agnosis CTCL,' mycosis CTCL• w1th Sczary 
fungoides type leukemia 
Durauon (years) 10 11 
Stagc1 Ill 11 
Previous Treatment None Electron beam Sy prior 
• CTCL, cutaneous T -cell lymphoma. 
1 Accordtng to Nattonal Cancer lnsntute S12ging Classtficatton JIJ. 
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F igure 1. Case I -plaque les10n: Photonucrograph ~howang classical fea-
tures of cutaneous T-celllymphoma wtth aryptcal dermal lymphocytic infil-
trate, ep1dermorropism, and the fonnauon of Pautrier microabscess (~rrow) 
(Hematoxylin and eosin, magnification X l 60). 
sary, co keep it frozen. The powdered n ssue was transferred into 2 
ml of0.5o/o sodium dodecyl sulfate/ 5 mM EDTA/ 300 mM NaCI/ 
10 mM Tris-HCI (pH 7.5)/0.2 mg/ml proteinase K and incubated 
overnight at 37"C with gentle agirarion. For extraction of DNA 
from cell suspensions (cultured T cells and peripheral blood mono-
nuclear cells), 2 ml of the same digestion buffer was added to each 
pellet of approximately 5 X 106 cells at room temperature and di-
gested as above. DNA was extracted from the digested lysates by 
sequencia! extractions with equal volumes of phenol, phenol-cho-
loroform, and chloroform. Traces of chloroform were removed by 
extraction with anhydrous ether, and the DNA was precipitated 
with 2 volumes of ethanol [4]. DNA concentrations were deter-
mined by absorbance at 260 nm. Samples containing 7.5 }1g DNA 
were digested with an excess of restriction endonucleases Eco R 1 or 
Hind III (BRL, Bethesda, MD) at 37"C for at lease 18 h in che buffer 
supplied by the manufacturer. Restricnon dtgests were size-frac-
tionated by electrophoresis in 0.8% agarose gels and transferred to 
nylon filters (Zeta Probe, Bio-Rad) using 0.4 N NaOH as described 
by the supplier. 32P-labcled eDNA probes were prepared by random 
priming [5] and the filters were hybridized under stringent condi-
tions and autoradiographed as previously described [6]. 
DNA Probes Rearrangements of the TCR-P chain gene were 
detected by a 400 basepair Ava 1/ Pst I fragment of the eDNA clone 
YT35 (7] (a gift of Dr. T. Mak). This probe, cp, hybridizes to boch 
constant regions of the T CR-P chain gene. T CR-y chain gene rear-
ra~ements were mapped by hybrization with a 700 basepair Hind 
Ill Eco Rl fragment ofhuman genomic DNA clone M1 3H60 [8] (a 
gi t of Dr. T . H. Rabbitts). This probe,Jy, hybridizes to both joining 
regions 1 and 2 of the TC R-y chain gene. 
RESULTS 
TCR P-Cha in Gene R earra ngem ent Studies 
Patieuc 1: Figure 2 displays autoradiographs of Southern blo~s of 
Eco R 1 and Hind III digests of genom1c DNA from the skmles1ons 
and T-cell clones of patient 1 hybridized against the Cp probe. No 
rearrangement was present in the patient's plaque lesion (Fig 2,/a~Je 
A), but a TCR-P chain gene rearrangement was clearly present m 
the patient's CTCL tumor (Fig 2, lam• B). Th1s gene rearrangement 
hkel y represents the rearrangement of the predominant (malignant) 
CTCL clone in the rumor tissue sampled. 
Of rhe T-cell clones derived from the patient's CTCL plaque 
(lesion A) , none was identical to ch~ predominan~ clo.ne .in ~he 
tumor. La11e 13 (Fig 2) showed a germlme configuration, md1canng 
that this clone was unrearranged at the TCR P-chain locus. Of the 
remaining 12 clones (la 11es 1- 12), at least one and sometimes more 
6 HO ET AL 
lvtr A 8 1 2 3 J 5 6 • 8 9 10 " 12 13 J lvt G 
-
-
. M G 
EcoRt 
Figure 2. Ca5e !-Southern blot analysts of CTCL skm lesions and T-cell 
clones: DNA samples were dtgcsted wtth lltnd 111 or EcoRI and hybndized 
to rhe cp probe to detect TCR P-cham gene rearrangements. Mr repre~ents 
size markers (23,9.4,6.6.4.2,2.3 kb and 9.4,6.6 kb m the Hind Ill and EcoR I 
blots. rcspecnvcly). A and B represent spectmens from patient's plaque and 
nnnor lesion, rc~pecnvdy. 1-13 represent T-cell clones derived from pa-
tient's plaque leston. Control specimen> are): Jurkat; M: Molr-4; G: genn-
hne. Dashes md1cate molecular sizes in kiloba,es of germline bands. The line 
berween asterisks mdtcates the posttion of rearrangemenr presenr m panenr's 
rumor lesion (B) The famr band below the 3.5-kb band in the Hind III blot 
represcnrs an arref.tct resulting from "star activtry." Taken together, the 
Hind Ill and EcoR I blots reveal that none of the T-cell clones have the same 
rearrangement as the patient's leston. 
than one rearranged band was present, indicating rearrangement of 
one or more allelles. Taken together, the Eco R 1 and Hind Ill blots 
revealed that these 12 clones all have different rearrangements indi-
cating that rhey were of different donal origms. 
T C R y-C hain Gene R earrangem ent Studies, Patient 1 
Analysis ofTCR-y chain gene rearrangements of this patient's skin 
lesions and T-cell clones revealed that identical rearrangements 
were present in both the plaque and tumor lesions (Fig 3). Of the 12 
clones analyzed (1-8 are shown in Fig 3), none had the same rear-
A 8 12345678 J G 
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Figure 3. Case 1-Souchern blot analysis of CTCL skm lesions and T-c~ll 
clones: DNA samples were dtgested with EcoRI and hybridized to the ]Y 
probe to detect T C R y-chain gene rearrangements. A and B represent speci-
mens from patient's plaque and rumor lesion, respecuvely. 1-8 represent 
clones denved from patient's plaque lesiOn, correspondmg to those in Fig 2. 
Control specnncns are), Jurkat; G, gem1line. Dashts mdicare molecular sizes 
in kilobases of germline bands. The lirrt between asterisks indtcates the posi-
tion of rearrangement presC'm in rhc patient's skm lestons. None of d1e 
T-cell clones have the same rearrangement as the skm lesion. 
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rangemenc as the parent skin lesiOn (lesion A). Thus, these data 
provide further support that the T-cell clones are distinct from the 
malignant clone in the skin lesion. 
TCR P-Chain Gene R earrangement Studies, Patient 2 
TCR-P chain gene rearrangement studies were performed on pe-
ripheral blood mononuclear cells, a skin lesion and T-cell clones 
denved from the skin lesion of this patient (Fig 4). DNA extracted 
from peripheral hlood mononuclear cells and from the slcin lesion 
had the same genotypic configuration. The rearranged band (Fig 4, 
lartr E) was 11 kh in size and was close to an artefactual l l.S-kb band 
that may be seen from partial Hind III restriction endonuclease 
digestion. However, several facts indicate chat the rearrangement 
was real: i) the same rearranged band was demonstrated in three 
separate experiments and in both the blood and skin lesion; ii) the 
absence of the 12.0 kb Eco R I fragment and the near-absence of3.5 
Hind Ill fragmenr (Fig 4, lane E) are consistenr with a deletional 
rearrangement of rhc cpt region and mdicates that DNA digestion 
was complete; and iii) TCRP-cham gene rearrangement could also 
be demonstrated using a third enzyme, Bam HI (data nor shown). 
As in the fim case, the T-cell clones derived from this patient's 
skin lesion had TCRP-chain gene rearrangements disti nct from the 
malignant clone, indicating that they were derived from T IL. On 
the Hmd III blot, clone 6 and clone 10 (Fig 4, lartes 6 and 1 0) each 
had a rearranged band in the same position as that of the malignant 
clone (Fig 4, /ant E). However, Eco Rl digestion revealed that 
clones 6 and 10 had generated rearranged bands not present in the 
malignant clone, indicating their distinct identity from rhe malig-
nant clone. 
TCR y-Chain Gene Rearrangement Studies, P atient 2 The 
TCR y-chain gene rearrangement data provide further support for 
this conclusion. A variety of TCR y-chain rearrangements were 
presenr in the clones derived from lesional skin, but none of these 
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Figure 4. Case 2-Southc:rn blot analysis of CTCL skin lesion and T-cell 
clones: DNA samples were dige~ted with Hindlll or EcoRI and hybridized 
to the CfJ probe to detect TCR fJ-cham gene rearrangements. E represents a 
specimen from the ratient's skin lesion. 1 - 12 are T -cell clone~ derived from 
thiS leston. Contro specimens are J, Jurkat: M, Molt-4; G, germ line. Daslres 
mdtcate molecular stzc~ m ktlobascs of gcrmltnc bands. The line berween 
asterisks indicates the position of rearrangement present in the patient's skin 
lesiOn. Tht" faint band below the 3.5-kb band m the Hmd Ill blot represents 
an artefact resultmg from "star activity." Taken together, the Hindlll and 
EcoR I blots indicate that none of the T -cell clones have the same rearrange-
ment as the patient's lesion. 
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Figure 5. Case 2-Somhcrn blot analysis of CTCL sktnlcsion and T-cell 
clones: DNA samples were digested wtth EcoR 1 and hybridized to the j )• 
probe to detect TCR y-chain gene rearrangements. E represents a specimen 
from a pari em's skin lesion. 1- 12 arc T -cell clones derived from this leswn. 
Control specimens are), J urkat; G, germhne. Dasltes indicate molecular sizes 
in kilobascs of gcrmlmc bands. A varicry of rearrangements are present in rhe 
clones. bur none was present in the sktn lesion. 
rearrangements was detccrable in the same skin lesions or in periph-
eral blood mononuclear cells (Fig 5). Two of the clones showed 
multiple rearrangements (clone 7 and 11 , Fig 5), consistent with 
intramolecular D-J rearrangements, although o ligoclonality due to 
contamination remains a possibility. 
DISCUSSION 
We have shown by TCR P-chain andy-chain gene rearrangements 
that none of the T-cell clones derived from CTCL skin lesions had 
the same genotypic configuration as that of the parent skin lesion. 
Only clone 10 (Fig 2,/aue 10, Hind Ill) showed a hybridizing band 
with mobility similar to that of the malignant clone. However, 
clone 10 is distinct from the dominant clone in the skin lesion 
because an additional 5-kb rearrangement was present after Hind III 
digestion. Additionally, the Eco R 1 digestion showed chat clone I 0 
had a 6-kb rearrangement, while the malignant clone has no such 
rearrangement (Fig 2). W e interpret that these T-cell clones, which 
are distinct from the maltgnant clone, represent non-malignant, 
reactive T cells. The presence of these reactive T cells supporrs our 
impression that the normal-appearing lymphocytes observed in his-
tologic sections of CT CL skin lesions are reactive inflammatory 
cells rather than cells of rhe malignant clonal lineage that have a 
normal phenotype. 
Our first patient clearly demonstrated a TCR P-chain gene rear-
rangement in the tumor lesion (lesion B), but no rearrangement was 
detectable in the plaque lesion (lesion A), even though the plaque 
contained an intense lymphocytic infiltrate with Pautrier microab-
scesses (Fig 1 ). This finding most likely indicates that the malignant 
clonal population in the plaque was below the level of detection by 
T CR P-chain gene rearrangement analysis, i.e., less than 5% of the 
T-cell population. This finding provides further evidence that reac-
tive, non-malignant T cells predominate in early CTCL skin le-
sions. 
Because malignant CTCL cel ls were clearly present in the skin 
lesions from which the T-cell clones were derived, the failure to 
propagate these cells in vitro suggests two possibilities. First, the 
CTCL cells have growth requirements not mer by conventional 
T-cell culturing condi tions; namely. the use of IL-2 and lectins as 
mitogens. Second, the in vitro conditions may have preferentially 
expanded the TIL which arc cytotoxic to rhe CT C L cells or are 
inhibitory to their growth. In any case, our results suggest the po-
tential feasibility of expanding TIL virntally free of malignant 
CT CL cells in vitro. It remains to be determined whether these TIL 
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have cytotoxic or growth inhibitory activity toward CTCL cells 
and whether they can be used for adoptive immunotherapy. 
In separate experiments, we and others [9] have observed that 
CT C L cells in cell lines derived from the peripheral blood mononu-
clear cel ls ofSezary leukemia patients disappear within a few weeks 
of in vitro culture with IL-2 and lectin stimulation, as indicated by 
the disappearance of the TCR gene rearrangement of the malignant 
clone upon genotypic analysis of the cultured cells. Some recent 
evidence has accumulated which may provide some clues as to why 
the CTCL cells did not survive in culture. CTCL cells have been 
shown to respond poorly co conventional T-cell mitogens, such as 
PHA and pokeweed mitogen [10,11]. We postulate chat CTCL 
cells may have growth requirements different from those of normal 
T-cclls. As the epidermis is capable of producing a variety ofT-cell 
growth promoting cytokines [12 - 16] and CTCL cells have a 
known affinity for the skin, it may be chat some of these epidennal-
derived cytokines are required for growth of the CTCL cells 
[1 2,17]. 
Of interest is the demonstration of a TCR }'-chain gene rear-
rangement without a P-chain gene rearrangement in the plaque 
lesion of patient 1. This finding may be explained by the fact that 
the T C R )'-chain rearrangement process is much more limited in 
diversity compared to P-chain gene rearrangement; therefore, the 
demonstration of a y-chain gene rearrangement may represent the 
presence, by chance, of several clones having the same rearrange-
ment rather than a monoclonal proliferation. H owever, the finding 
of the same rearrangement in the plaque and rhe tumor, and the fact 
that none of the 12 T -cell clones derived from rhe plaque showed 
rhe same rearrangement, would argue against this explanation. An 
alternative explanation is chat there were malignant T cells that had 
only rearranged their }'-chain genes bur nor their P-chain genes. 
This phenomenon has been reported in T-celllcukemias and lym-
phomas [18-22] but, to our knowledge, has nor been reported in 
CTCL. 
Ano ther interesting observation worthy of comment is the find-
ing of an unusual sequence of TCR gene rearrangements. In our 
first case, clone 6 and clone 8 demonstrated rearrangement of the 
T CR-P chain gene (Fig 2) but germline configuration of the TCR-y 
chain gene (Fig 3). Our second case demonstrated rearrangement of 
the T CR-P chain gene but not the T CR-y chain gene in the pa-
tient's skin lesion or peripheral blood (Figs 4 laue E, and 5), as 
previously documented [23). These findings were unexpected in 
light of the prevailing concept ofT-cell ontogeny which depicts an 
orderly sequence ofTCR gene rearrangement of the yjO-chain fol-
lowed by the a/P-chain. It is possible that the ]Y probe or the 
restriction enzymes used might not have detected all possible rear-
rangements of the T CR-y chain gene. Unfortunately, there was 
insufficient DNA to test these possibilities. Alternatively, there may 
be TCR-ajp receptor bearing cells that may bypass the T CR-y 
chain gene rearrangement process. Whether these cells represent 
malignant cells or a variant of reactive cells ca1mot be answered in 
our study. If these cells were malignant cells, one would have to 
postulate the presence of more than one malignant clone in CT C L 
or the formation of malignant subclones in CTCL lesions, as these 
clones have T C R rearrangements distinct from the predominant 
malignant clone in the skin lesion. These are intriguing possibilities 
bur lack experimental support. 
In summary, T cells of multiple clonal origins with TCRPand y 
chain gene rearrangements distinct from the predominant (presum-
ably malignant) clone are present in CTCL skin lesions. These 
presumably reactive (non-malignant) T cells or so-called TIL may 
be extracted from CT CL skin lesions and expanded in vitro using 
conventional T -cell culture conditions with IL-2 and periodic PHA 
stimulation. In contrast, CTCL cells cannot be propagated in these 
culture conditions. Our data suggest that CTCL cells may have 
different growth requirements in comparison to normal T-cells. 
The use of conventional T-cell culturing method with IL-2 and 
PHA may selectively propagate non-malignant T cells. Whether 
these TIL are suitable for use in adoptive immunotherapy remains to 
be determined. 
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